Literature DB >> 2460263

Novel purification of vitronectin from human plasma by heparin affinity chromatography.

T Yatohgo1, M Izumi, H Kashiwagi, M Hayashi.   

Abstract

The glycoprotein vitronectin (also called S-protein, serum spreading factor, or epibolin) promotes spreading of a variety of cultured cells, inhibits the cytotoxicity of membrane attack complex C5b-9, and modulates thrombin-antithrombin III activity. We developed a strikingly simple method to purify vitronectin from human plasma by heparin affinity chromatography. Serum was obtained from plasma by adding calcium and then centrifuging. The heparin-binding activity of vitronectin in human serum was activated with 8 M urea. The activated vitronectin specifically bound to heparin-Sepharose in 8 M urea and was eluted with 0.5 M NaCl containing 8 M urea. This procedure resulted in an approximately 250-fold purification of vitronectin with a 15-30% recovery; 3-6 mg of pure vitronectin were obtained from 100 ml human plasma within 2 days. The purified vitronectin preparations promoted spreading of BHK fibroblastic cells on substrates with a half-maximal activity at only 0.1 microgram/ml. This new method is very simple, rapid, inexpensive, and flexible. It could probably be readily scaled up for commercial applications.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460263     DOI: 10.1247/csf.13.281

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  139 in total

1.  Presence of a laminin-binding chondroitin sulfate proteoglycan at the cell surface of a human melanoma cell Mel-85.

Authors:  M C Elias; S S Veiga; W Gremski; M A Porcionatto; H B Nader; R R Brentani
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

2.  Sulfated polysaccharide-directed recruitment of mammalian host proteins: a novel strategy in microbial pathogenesis.

Authors:  T D Duensing; J S Wing; J P van Putten
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Activation of alpha(v)beta3-vitronectin binding is a multistage process in which increases in bond strength are dependent on Y747 and Y759 in the cytoplasmic domain of beta3.

Authors:  D Boettiger; F Huber; L Lynch; S Blystone
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

4.  Inhibition of endothelial cell survival and angiogenesis by protein kinase A.

Authors:  Semi Kim; Manjiri Bakre; Hong Yin; Judith A Varner
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Vitronectin expression in differentiating neuroblastic tumors: integrin alpha v beta 5 mediates vitronectin-dependent adhesion of retinoic-acid-differentiated neuroblastoma cells.

Authors:  C L Gladson; C Dennis; T C Rotolo; D R Kelly; J R Grammer
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

6.  EMILIN-1 deficiency induces elastogenesis and vascular cell defects.

Authors:  Miriam Zanetti; Paola Braghetta; Patrizia Sabatelli; Isabella Mura; Roberto Doliana; Alfonso Colombatti; Dino Volpin; Paolo Bonaldo; Giorgio M Bressan
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

7.  Role of scaffold protein afadin dilute domain-interacting protein (ADIP) in platelet-derived growth factor-induced cell movement by activating Rac protein through Vav2 protein.

Authors:  Yuri Fukumoto; Souichi Kurita; Yoshimi Takai; Hisakazu Ogita
Journal:  J Biol Chem       Date:  2011-10-25       Impact factor: 5.157

8.  Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.

Authors:  L Milis; C A Morris; M C Sheehan; J A Charlesworth; B A Pussell
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

9.  Granulocyte-macrophage and macrophage colony-stimulating factors differentially regulate alpha v integrin expression on cultured human macrophages.

Authors:  M O De Nichilo; G F Burns
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

10.  Immunopathological features of rat Staphylococcus aureus arthritis.

Authors:  T Bremell; S Lange; R Holmdahl; C Rydén; G K Hansson; A Tarkowski
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.